Rhee Soo-Yon, Gonzales Matthew J, Kantor Rami, Betts Bradley J, Ravela Jaideep, Shafer Robert W
Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Nucleic Acids Res. 2003 Jan 1;31(1):298-303. doi: 10.1093/nar/gkg100.
The HIV reverse transcriptase and protease sequence database is an on-line relational database that catalogues evolutionary and drug-related sequence variation in the human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease enzymes, the molecular targets of antiretroviral therapy (http://hivdb.stanford.edu). The database contains a compilation of nearly all published HIV RT and protease sequences, including submissions to GenBank, sequences published in journal articles and sequences of HIV isolates from persons participating in clinical trials. Sequences are linked to data about the source of the sequence, the antiretroviral drug treatment history of the person from whom the sequence was obtained and the results of in vitro drug susceptibility testing. Sequence data on two new molecular targets of HIV drug therapy--gp41 (cell fusion) and integrase--will be added to the database in 2003.
HIV逆转录酶和蛋白酶序列数据库是一个在线关系数据库,它对人类免疫缺陷病毒(HIV)逆转录酶(RT)和蛋白酶这两种抗逆转录病毒治疗的分子靶点中的进化及与药物相关的序列变异进行编目(http://hivdb.stanford.edu)。该数据库汇集了几乎所有已发表的HIV RT和蛋白酶序列,包括提交给GenBank的序列、期刊文章中发表的序列以及参与临床试验人员的HIV分离株序列。序列与有关序列来源的数据、获得该序列的人员的抗逆转录病毒药物治疗史以及体外药敏试验结果相关联。HIV药物治疗的两个新分子靶点——gp41(细胞融合)和整合酶——的序列数据将于2003年添加到该数据库中。